Literature DB >> 11384622

Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition.

H Akiyama1, H Kondo, K Ikeda, M Kato, P L McGeer.   

Abstract

We investigated the immunohistochemical localization of neprilysin, a putative amyloid beta-protein (Abeta)-degrading enzyme, in postmortem human brain tissues. In the cerebral cortex, neprilysin immunoreactivity was weak, but relatively dense distribution was found in the primary somatosensory and visual cortices compared with the hippocampus and association cortices. In Alzheimer brain, neprilysin-positive dystrophic neurites occurred in senile plaques in the primary cortices, an observation that supports the relative abundance of neprilysin-positive neuronal processes. A paucity of neprilysin in the hippocampus and association cortices may contribute to the vulnerability of these areas to Abeta deposition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384622     DOI: 10.1016/s0006-8993(01)02390-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.

Authors:  Julia M Coppola; Christin A Hamilton; Mahaveer S Bhojani; Martha J Larsen; Brian D Ross; Alnawaz Rehemtulla
Journal:  Anal Biochem       Date:  2007-01-17       Impact factor: 3.365

2.  Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide(1-40) in mouse brain.

Authors:  Shingo Ito; Kohta Matsumiya; Sumio Ohtsuki; Junichi Kamiie; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

3.  In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin.

Authors:  Hui Huang; Syed Waseem Bihaqi; Liuxin Cui; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2011-02-18       Impact factor: 4.294

4.  Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolism.

Authors:  María C Leal; Ezequiel I Surace; María P Holgado; Carina C Ferrari; Rodolfo Tarelli; Fernando Pitossi; Thomas Wisniewski; Eduardo M Castaño; Laura Morelli
Journal:  Biochim Biophys Acta       Date:  2011-10-19

5.  Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.

Authors:  John B Rose; Leslie Crews; Edward Rockenstein; Anthony Adame; Michael Mante; Louis B Hersh; Fred H Gage; Brian Spencer; Rewati Potkar; Robert A Marr; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

6.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

Review 7.  Prion protein and Alzheimer disease.

Authors:  Katherine A B Kellett; Nigel M Hooper
Journal:  Prion       Date:  2009-10-02       Impact factor: 3.931

8.  Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.

Authors:  Mitsuru Shinohara; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

9.  Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40.

Authors:  J Y Huang; A M Bruno; C A Patel; A M Huynh; K D Philibert; M J Glucksman; R A Marr
Journal:  Neuroscience       Date:  2008-05-16       Impact factor: 3.590

10.  Association of neprilysin polymorphism with cerebral amyloid angiopathy.

Authors:  M Yamada; N Sodeyama; Y Itoh; A Takahashi; E Otomo; M Matsushita; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.